BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24262192)

  • 1. Aldehyde dehydrogenase 2 in sporadic Parkinson's disease.
    Michel TM; Käsbauer L; Gsell W; Jecel J; Sheldrick AJ; Cortese M; Nickl-Jockschat T; Grünblatt E; Riederer P
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S68-72. PubMed ID: 24262192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldehyde dehydrogenase (ALDH) in Alzheimer's and Parkinson's disease.
    Grünblatt E; Riederer P
    J Neural Transm (Vienna); 2016 Feb; 123(2):83-90. PubMed ID: 25298080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease.
    Goldstein DS; Sullivan P; Holmes C; Miller GW; Alter S; Strong R; Mash DC; Kopin IJ; Sharabi Y
    J Neurochem; 2013 Sep; 126(5):591-603. PubMed ID: 23786406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease.
    Wey MC; Fernandez E; Martinez PA; Sullivan P; Goldstein DS; Strong R
    PLoS One; 2012; 7(2):e31522. PubMed ID: 22384032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease.
    Goldstein DS; Sullivan P; Cooney A; Jinsmaa Y; Kopin IJ; Sharabi Y
    J Neurochem; 2015 Apr; 133(1):14-25. PubMed ID: 25645689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of aldehyde dehydrogenase 1A1 modulators using virtual screening.
    Kotraiah V; Pallares D; Toema D; Kong D; Beausoleil E
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):489-94. PubMed ID: 22380773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy.
    Goldstein DS; Sullivan P; Holmes C; Kopin IJ; Sharabi Y; Mash DC
    Parkinsonism Relat Disord; 2015 Jun; 21(6):567-72. PubMed ID: 25829070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased activity of mitochondrial aldehyde dehydrogenase (ALDH) in the putamen of individuals with Alzheimer's disease: a human postmortem study.
    Michel TM; Gsell W; Käsbauer L; Tatschner T; Sheldrick AJ; Neuner I; Schneider F; Grünblatt E; Riederer P
    J Alzheimers Dis; 2010; 19(4):1295-301. PubMed ID: 20061610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of aldehyde dehydrogenase 2 activation in rotenone-induced cellular and animal models of parkinsonism.
    Chiu CC; Yeh TH; Lai SC; Wu-Chou YH; Chen CH; Mochly-Rosen D; Huang YC; Chen YJ; Chen CL; Chang YM; Wang HL; Lu CS
    Exp Neurol; 2015 Jan; 263():244-53. PubMed ID: 25263579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldehyde dehydrogenase 2 in the spotlight: The link between mitochondria and neurodegeneration.
    Deza-Ponzio R; Herrera ML; Bellini MJ; Virgolini MB; Hereñú CB
    Neurotoxicology; 2018 Sep; 68():19-24. PubMed ID: 29936317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benomyl, aldehyde dehydrogenase, DOPAL, and the catecholaldehyde hypothesis for the pathogenesis of Parkinson's disease.
    Casida JE; Ford B; Jinsmaa Y; Sullivan P; Cooney A; Goldstein DS
    Chem Res Toxicol; 2014 Aug; 27(8):1359-61. PubMed ID: 25045800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease.
    Fitzmaurice AG; Rhodes SL; Cockburn M; Ritz B; Bronstein JM
    Neurology; 2014 Feb; 82(5):419-26. PubMed ID: 24491970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High and complementary expression patterns of alcohol and aldehyde dehydrogenases in the gastrointestinal tract: implications for Parkinson's disease.
    Westerlund M; Belin AC; Felder MR; Olson L; Galter D
    FEBS J; 2007 Mar; 274(5):1212-23. PubMed ID: 17257171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know.
    Goldstein DS
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.
    Mandel S; Grunblatt E; Riederer P; Amariglio N; Jacob-Hirsch J; Rechavi G; Youdim MB
    Ann N Y Acad Sci; 2005 Aug; 1053():356-75. PubMed ID: 16179542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Alterations in Metabolism and Proteolysis-Related Proteins in Human Parkinson's Disease Substantia Nigra.
    Grünblatt E; Ruder J; Monoranu CM; Riederer P; Youdim MB; Mandel SA
    Neurotox Res; 2018 Apr; 33(3):560-568. PubMed ID: 29218503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldehyde dehydrogenase inhibition generates a reactive dopamine metabolite autotoxic to dopamine neurons.
    Doorn JA; Florang VR; Schamp JH; Vanle BC
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1(0 1):S73-5. PubMed ID: 24262193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic remodeling induced by mitochondrial aldehyde stress stimulates tolerance to oxidative stress in the heart.
    Endo J; Sano M; Katayama T; Hishiki T; Shinmura K; Morizane S; Matsuhashi T; Katsumata Y; Zhang Y; Ito H; Nagahata Y; Marchitti S; Nishimaki K; Wolf AM; Nakanishi H; Hattori F; Vasiliou V; Adachi T; Ohsawa I; Taguchi R; Hirabayashi Y; Ohta S; Suematsu M; Ogawa S; Fukuda K
    Circ Res; 2009 Nov; 105(11):1118-27. PubMed ID: 19815821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression pattern, ethanol-metabolizing activities, and cellular localization of alcohol and aldehyde dehydrogenases in human large bowel: association of the functional polymorphisms of ADH and ALDH genes with hemorrhoids and colorectal cancer.
    Chiang CP; Jao SW; Lee SP; Chen PC; Chung CC; Lee SL; Nieh S; Yin SJ
    Alcohol; 2012 Feb; 46(1):37-49. PubMed ID: 21940137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydroxyphenylacetaldehyde Lowering Treatment Improves Locomotor and Neurochemical Abnormalities in the Rat Rotenone Model: Relevance to the Catecholaldehyde Hypothesis for the Pathogenesis of Parkinson's Disease.
    Khashab R; Gutman-Sharabi N; Shabtai Z; Landau R; Halperin R; Fay-Karmon T; Leibowitz A; Sharabi Y
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.